Cobra Biologics (Cobra), an international contract development and manufacturing organisation (CDMO) focused on viral vector drug substance production, and Symbiosis Pharmaceutical Services (Symbiosis), a contract manufacturing organisation (CMO) specialising in the sterile manufacture of injectable viral vector drug products, today announced the successful completion of their collaboration to develop synergistic and world leading capabilities. Intended to accelerate the clinical and commercial production of viral vectors,...
Scotland has ambitions to increase turnover in Life Sciences to £8bn by 2025. To achieve this, a key enabler for this ambition will be the extent to which the sectors embrace the digital revolution and the Industry 4.0 philosophy. The Sustainable Production Group, part of the wider Life Sciences Scotland Strategy, developed a digital workshop, which saw the coming together of members of the life...
The winners of Scottish EDGE Round 14 have been announced with designer sustainable wooden bag manufacturer, Roccio, taking the inaugural Circular Economy EDGE Award. Top Higgs EDGE Award of £125,000 given to crop production refiner, Myconourish Glasgow teenager who founded his business while battling cancer takes five-figure award in Young EDGE category Sixth year pupil takes five figure sum in Wild Card EDGE for life-saving bagpipe...
Working with Catalonia Trade and Investment (ACCIÓ), Scottish Enterprise (SE) is investing at least £1 million to fund international collaborations that lead to new products, services or processes in the areas of Healthcare, manufacturing 4.0 and mobility. This is an exciting opportunity for Scottish healthcare companies of all sizes looking to develop world class innovations, linking them with leading players in Catalonia: not just facilitating...
Synpromics Ltd, the leader in gene control, and Lonza Pharma & Biotech announce a partnership for the commercialisation of a number of inducible promoters to improve the manufacturing of biopharmaceuticals. The commercial agreement with Lonza follows the award of an Innovate UK grant to Synpromics announced on 23 April 2018. Lonza and Synpromics worked together to develop and test these innovative promoters in Lonza’s industry-leading GS Xceed®Expression System. The inducible...
Researchers from Heriot-Watt University’s Natantis team are developing an innovative device that could revolutionise the way blood samples are prepared for use in cancer diagnosis. The Natantis team, which hopes to spin-out into a commercial venture by 2020, has created the CNAsafe device to extract cell-free nucleic acids (cfNA) from whole blood. The demand for the type of testing this facilitates – known as liquid...
Freeline, a biotechnology company focused on developing curative gene therapies for chronic systemic diseases, has secured a collaborative grant of £1.3 million from Innovate UK to lead a supply chain model and delivery development project in partnership with Symbiosis Pharmaceutical Services (Symbiosis) and the Cell and Gene Therapy Catapult (CGTC). The project is intended to create a UK based novel viral vector supply chain and to increase the speed...
TC BioPharm (TCB), a developer of allogeneic CAR-T immuno-oncology products, and leaders in Gamma Delta T (GDT) cell therapies, today announced it has initiated a Phase I clinical study of TCB002, an allogeneic cell therapy consisting of activated and expanded gamma delta T cells. The trial, for treatment of patients suffering from Acute Myeloid Leukemia (AML), is being conducted at the Institute of Hematology and...
Ambitious plans to boost the economic impact of Scotland’s burgeoning industrial biotechnology sector have received early-stage funding from UK Research and Innovation (UKRI). The project, led by the Industrial Biotechnology Innovation Centre (IBioIC), the University of Strathclyde and involving a consortium of collaborative partners, aims to accelerate the development of biology-based products for a wide range of sectors, from health to agriculture and the marine...
RoslinCT, a leading cell gene therapy contract manufacturing organisation, is pleased to announce the appointment of David Bowie to the Board of Directors. David has over twenty-eight years of international sales, marketing management and business development experience in the global healthcare sector which led him to the board of the Scottish Government backed Life Science Scotland industry Leadership Group for some 12 years. David brings...